JPH01202659A - Reagent composition and test piece for detecting component in body fluid - Google Patents
Reagent composition and test piece for detecting component in body fluidInfo
- Publication number
- JPH01202659A JPH01202659A JP2851588A JP2851588A JPH01202659A JP H01202659 A JPH01202659 A JP H01202659A JP 2851588 A JP2851588 A JP 2851588A JP 2851588 A JP2851588 A JP 2851588A JP H01202659 A JPH01202659 A JP H01202659A
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- test piece
- body fluid
- reagent composition
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 44
- 238000012360 testing method Methods 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 210000001124 body fluid Anatomy 0.000 title claims abstract description 22
- 239000010839 body fluid Substances 0.000 title claims abstract description 22
- 229920001225 polyester resin Polymers 0.000 claims abstract description 15
- 239000004645 polyester resin Substances 0.000 claims abstract description 15
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 4
- -1 alkali metal sulfonate compound Chemical class 0.000 claims description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 125000001174 sulfone group Chemical group 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 238000004519 manufacturing process Methods 0.000 abstract description 15
- 238000000576 coating method Methods 0.000 abstract description 6
- 229920000728 polyester Polymers 0.000 abstract description 6
- 239000011248 coating agent Substances 0.000 abstract description 5
- 230000035515 penetration Effects 0.000 abstract description 2
- 150000001339 alkali metal compounds Chemical class 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 239000011347 resin Substances 0.000 description 9
- 239000002952 polymeric resin Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 229920003002 synthetic resin Polymers 0.000 description 5
- 210000000601 blood cell Anatomy 0.000 description 4
- 239000000976 ink Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- DAMJCWMGELCIMI-UHFFFAOYSA-N benzyl n-(2-oxopyrrolidin-3-yl)carbamate Chemical compound C=1C=CC=CC=1COC(=O)NC1CCNC1=O DAMJCWMGELCIMI-UHFFFAOYSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940039227 diagnostic agent Drugs 0.000 description 2
- 239000000032 diagnostic agent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- WOZVHXUHUFLZGK-UHFFFAOYSA-N dimethyl terephthalate Chemical compound COC(=O)C1=CC=C(C(=O)OC)C=C1 WOZVHXUHUFLZGK-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 229920003009 polyurethane dispersion Polymers 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- VNGOYPQMJFJDLV-UHFFFAOYSA-N dimethyl benzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC=CC(C(=O)OC)=C1 VNGOYPQMJFJDLV-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229910052920 inorganic sulfate Inorganic materials 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N n-butyl methyl ketone Natural products CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920006289 polycarbonate film Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- LLHSEQCZSNZLRI-UHFFFAOYSA-M sodium;3,5-bis(methoxycarbonyl)benzenesulfonate Chemical compound [Na+].COC(=O)C1=CC(C(=O)OC)=CC(S([O-])(=O)=O)=C1 LLHSEQCZSNZLRI-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- NUBZKXFFIDEZKG-UHFFFAOYSA-K trisodium;5-sulfonatobenzene-1,3-dicarboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=CC(C([O-])=O)=CC(S([O-])(=O)=O)=C1 NUBZKXFFIDEZKG-UHFFFAOYSA-K 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は体液中成・分検出用試薬組成物及びそれを用い
た試験片に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a reagent composition for detecting components in body fluids and a test piece using the same.
〔従来の技術及び発明が解決しようとする課題3体液中
の成分を分析する手段として、近年、試験片を利用した
いわゆるドライケiス) IJ −が発達してきた。尿
中の楯、蛋白、 pHを測定する試験片が開発されたの
を初めとして、さらに新たな尿中成分を測定する項目が
追加され、現在においては、これら試験片を用いた半定
量法による簡易診断法が確立されている。さらに、体液
、殊に血液中の成分についても、ドライケミストリーの
手法を使った試験片によって測定されるようになってき
た。特に血液中のグルコースを測定するための試験片は
、糖尿病のような血液中のグルコース濃度を一定に保つ
必要のに役立てている。[Problems to be Solved by the Prior Art and the Invention 3 In recent years, as a means for analyzing components in body fluids, so-called dry case (IJ-I) using test pieces has been developed. In addition to the development of test strips for measuring urinary shield, protein, and pH, new items for measuring urine components have been added, and now semi-quantitative methods using these test strips are being developed. A simple diagnostic method has been established. Furthermore, components in body fluids, especially blood, have come to be measured using test pieces using dry chemistry techniques. In particular, test strips for measuring glucose in the blood are useful in cases such as diabetes where it is necessary to maintain a constant blood glucose concentration.
このような試験片を製造するために、従来は担体として
F紙を用い、特定の成分を検出するための試薬を含浸し
た後、さらに血球等を除くための手段として、高分子化
合物を被覆する方法がとられてきた。しかし、この方法
は試験片の製造が繁雑で、かつ、試験片自身のばらつき
が大きい等の欠点を有していた。In order to manufacture such test pieces, conventionally, F paper is used as a carrier, which is impregnated with a reagent for detecting a specific component, and then coated with a polymer compound as a means to remove blood cells, etc. methods have been taken. However, this method has drawbacks such as complicated manufacturing of test pieces and large variations in the test pieces themselves.
特開昭59.22B166号公報にはこれを改良したも
のとして、部分的に架橋された高分子化合物を、さらに
上部に被覆する方法が開示されている。この被覆によっ
て、過゛剰の試料例えば血液を、ふきとりによって取り
除く際に有利になるとされているが、ここでは親水性の
蛋白質又は炭水化物を使っているため、再溶解による接
着現象が見られるほか、製造段階で何度も担体であるF
紙を処理するため、その製造工程がさらに増したものと
なっている。JP-A-59.22B166 discloses, as an improvement on this, a method in which a partially crosslinked polymer compound is further coated on top. This coating is said to be advantageous when removing excess samples, such as blood, by wiping, but since hydrophilic proteins or carbohydrates are used here, adhesion phenomena due to re-dissolution are observed, and F, which is a carrier, is used many times during the manufacturing stage.
The manufacturing process has been further increased to process paper.
そこで、最近、単層又は多層のフィルム状組成物を使用
したドライケはストリーが開発されてきている。特公昭
49− !l!1800号公報、特開昭55−1254
53号公報には、試薬が均一に分配された耐水性フィル
ムからなる、単層の診断剤について開示されている。該
診断剤は、エチルセルロース、アセチルセルロース、ポ
リ酢酸ビニル、ポリプロピオン酸ビニル、ポリビニルブ
チルアセタール、ラテックス等の有機溶剤に可溶である
か、又は、水に分散可能なフィルム形成成分と試薬成分
とを分散状態で混合し、支持体に塗布、乾燥させて得ら
れる本のである。必要に応じて、無機又は有機の不溶性
微細粒子をフィルム開放剤として用いること本できる。Therefore, recently, dryke streaks using single-layer or multi-layer film compositions have been developed. Tokuko Showa 49-! l! Publication No. 1800, JP-A-55-1254
No. 53 discloses a single-layer diagnostic agent consisting of a water-resistant film in which reagents are uniformly distributed. The diagnostic agent contains a film-forming component and a reagent component that are soluble in organic solvents such as ethyl cellulose, acetyl cellulose, polyvinyl acetate, polyvinyl propionate, polyvinyl butyl acetal, or latex, or are dispersible in water. It is obtained by mixing in a dispersed state, applying it to a support, and drying it. If necessary, inorganic or organic insoluble fine particles can be used as a film release agent.
この方法によって得られた試験片は、一定時間血液と反
応させた後血球の除去を行うと、成分濃度に厄じた色調
が得られるものであるが、元々疎水性のフィルム形成成
分を使用しているため反応に要する時間が長く、又、呈
色が安定するまでも長い時間を要するものであった。さ
らに、フィルム形成成分と試薬成分とを分散する場合に
おいても、均一な分散状態を得るのが難しいという欠点
も持っている。The test pieces obtained by this method, when blood cells are removed after reacting with blood for a certain period of time, can obtain a color tone that is problematic due to the concentration of the components, but it does not use hydrophobic film-forming components to begin with. Therefore, it took a long time for the reaction to occur, and it also took a long time for the coloring to become stable. Furthermore, even when dispersing film-forming components and reagent components, it is difficult to obtain a uniform dispersion state.
特開昭62i19454号公報には単層の透明な試薬担
体層について開示されている。該試薬担体層は、水溶性
又は水膨潤性成分及び本質的に不溶性のフィルム形成成
分からなり、フィルム形成成分としてはセルロースエス
テル、ポリ酢酸ビニル、ボリアミドのような高分子重合
体もしくは、非イオン性又はイオン性ポリウレタン分散
体を使用している。ここでの特徴は、水膨潤性成分とフ
ィルム形成成分との混合比を一定の範囲にすることで、
この比は1:1〜1:50、好ましくはに5〜1:10
としている。従って、該試薬担体層を作るためには、フ
ィルム形成成分単独では、それ自身本質的に不溶性なた
め不十分で、水溶性又は水膨潤性成分が不可欠である。JP-A-62-19454 discloses a single transparent reagent carrier layer. The reagent carrier layer consists of a water-soluble or water-swellable component and an essentially insoluble film-forming component, and the film-forming component is a high molecular weight polymer such as cellulose ester, polyvinyl acetate, polyamide, or a nonionic component. Or using an ionic polyurethane dispersion. The feature here is that the mixing ratio of the water-swellable component and the film-forming component is kept within a certain range.
This ratio is between 1:1 and 1:50, preferably between 5 and 1:10.
It is said that Therefore, in order to form the reagent carrier layer, the film-forming component alone is insufficient because it is essentially insoluble in itself, and a water-soluble or water-swellable component is essential.
又、本質的に水不溶性の成分と水膨潤性成分を混合する
ため、両者の溶媒又は希釈剤に同様のものを用いる必要
があるほか、均一な分散状態を得ることが難しく製造技
術を要するものである。In addition, since an essentially water-insoluble component and a water-swellable component are mixed, it is necessary to use the same solvent or diluent for both, and it is difficult to obtain a uniform dispersion state and requires manufacturing technology. It is.
多層のフィルム状組成物に関しては、特公昭56−45
599号公報、同昭58−18628号公報、特開昭5
6−24576号公報及び同昭57−66559号公報
に開示されている。これらの構造は一般的に、展開層、
試薬層、検出層を支持体上に積層してなるものであり、
展開層に、体液、殊に血清を滴下し、一定時間反応後に
透明な支持体を通して検出層の呈色を検出するものであ
る。Regarding multilayer film compositions, Japanese Patent Publication No. 56-45
Publication No. 599, Publication No. 58-18628, Japanese Unexamined Patent Application Publication No. 1973
It is disclosed in Japanese Patent No. 6-24576 and Japanese Patent No. 57-66559. These structures generally consist of a deployment layer,
It is made by laminating a reagent layer and a detection layer on a support,
A body fluid, particularly serum, is dropped onto the developing layer, and after reaction for a certain period of time, the color development of the detection layer is detected through a transparent support.
従って、これらはその専用読み取り装置が必要々もので
、前述のような簡単に測定する手段としては考えにくい
。又、該フィルムを積層するには特別な装置が必要で、
製造上困難なうえコスト面でも高価にならざるを得ない
。Therefore, a dedicated reading device is required for these, and it is difficult to imagine them as a simple means of measurement as described above. Additionally, special equipment is required to laminate the film.
In addition to being difficult to manufacture, it is also expensive in terms of cost.
本発明は上記従来技術における問題点を解決するための
ものである。The present invention is intended to solve the problems in the prior art described above.
本発明の第1の目的は、体液中、殊に血液中の特定成分
を検出するための、製造が容易で判定結果が正確かつ迅
速に得られる試薬組成物を提供することである。A first object of the present invention is to provide a reagent composition for detecting a specific component in body fluids, particularly blood, which is easy to manufacture and allows accurate and rapid determination results.
本発明の第2の目的は、上記試薬組成物を用いた、複雑
な製造工程・製造装置を使うことなく製造可能であり、
安価で使い易く信頼性の高い試験片を提供することであ
る。A second object of the present invention is that the reagent composition described above can be manufactured without using complicated manufacturing processes or manufacturing equipment;
The objective is to provide a test piece that is inexpensive, easy to use, and highly reliable.
本発明者らは、これらの条件を兼ね備えた組放物及び試
験片を得るべく鋭意研究した結果、体液中の特定成分を
検出するための試薬とスルホン化されたポリエステル樹
脂を混合した組成物及びそれを支持体上に塗布し、一定
の温度で乾燥後得られた試験片が、上記の性能を有する
ことを見いだし本発明を完成させるに至った。As a result of intensive research in order to obtain a recombinant and a test piece that meet these conditions, the present inventors have developed a composition in which a reagent for detecting specific components in body fluids is mixed with a sulfonated polyester resin; It was found that the test piece obtained after coating the same on a support and drying at a constant temperature had the above-mentioned performance, leading to the completion of the present invention.
すなわち本発明の体液中成分検出用試薬組成物は、体液
中の特定成分を検出するための試薬と、該試薬の担体と
してのスルホン化されたポリエステル樹脂とよりなるこ
とを特徴とするものである。That is, the reagent composition for detecting components in body fluids of the present invention is characterized by comprising a reagent for detecting a specific component in body fluids and a sulfonated polyester resin as a carrier for the reagent. .
一般に、高分子樹脂は有機溶媒に溶かして、塗料、イン
キ、フィルム、接着剤等の原料として使用されてきたが
、近年、有機溶媒の揮発による溶媒具や引火による火災
の危険性などの見地から、より安全な方向として水溶化
についての研究がなされてきた。樹脂を水溶化するため
の手段としては、樹脂骨格中に親水性の置換基を導入し
、通常は親水基の塩の形で存在させることが一般的であ
り、その親水基の型により犬きく二つの形、つまりアニ
オン型とカチオン型に分けることができる。これらの水
溶性高分子樹脂は、乳化剤を使用することなく水溶液状
態を得ることが可能であシ、かくして有機溶媒を使用し
ない純粋に水系の高分子樹脂液ができることになった。Generally, polymer resins have been dissolved in organic solvents and used as raw materials for paints, inks, films, adhesives, etc. However, in recent years, polymer resins have been used as raw materials for paints, inks, films, adhesives, etc.; , research has been conducted on water solubilization as a safer direction. A common way to make a resin water-soluble is to introduce a hydrophilic substituent into the resin skeleton, usually in the form of a salt of the hydrophilic group. It can be divided into two forms: anionic and cationic. It is possible to obtain an aqueous solution state of these water-soluble polymer resins without using an emulsifier, and thus a purely aqueous polymer resin liquid without using an organic solvent can be produced.
具体的な親水化の方策としては、はじめから親水基の塩
をもった原料を使用する方法、例えば、5−スルホイソ
フタル酸・ナトリウム塩のようなジカルボン酸を共重合
して樹脂を得る方法や、塩を形成する能力をもった置換
基をあらかじめ導入しておいたのち親水化する方法、例
えば、酸価の高いポリエステルの残存カルボン酸をアル
カリで中和する方法等がある。さらには、不飽和結合を
もった高分子樹脂に無機硫酸塩を付加するような高分子
量化に直接無関係な反応で親水基を導入する方法もある
。Specific measures for making the resin hydrophilic include a method of using raw materials that have a salt of a hydrophilic group from the beginning, for example, a method of obtaining a resin by copolymerizing a dicarboxylic acid such as 5-sulfoisophthalic acid sodium salt; There is a method in which a substituent having the ability to form a salt is introduced in advance and then made hydrophilic, for example, a method in which residual carboxylic acid in a polyester having a high acid value is neutralized with an alkali. Furthermore, there is also a method of introducing hydrophilic groups by a reaction not directly related to increasing the molecular weight, such as adding an inorganic sulfate to a polymer resin having unsaturated bonds.
驚くべきことに、塗料やインキ等の基材として開発され
たこのような水溶性高分子樹脂の中でi?にスルホン化
されたポリエステル樹脂は、体液中の特定成分を検出す
る試薬と混合し一定の厚さで塗布した後、一定の温度で
乾燥してフィルム状にすると、単層でありながらある稲
の体液中の高分子物質、例えば、赤血球等を除去する性
能を有するとともに、目的とする成分は浸透させ反応を
行うことができることを見いだした。Surprisingly, among such water-soluble polymer resins developed as base materials for paints and inks, i? The sulfonated polyester resin is mixed with a reagent that detects specific components in body fluids, coated at a certain thickness, and then dried at a certain temperature to form a film. It has been discovered that it has the ability to remove polymeric substances such as red blood cells from body fluids, and can also penetrate and react with target components.
本発明に使用するスルホン化されたポリエステル樹脂と
しては、例えば大日本インキ化学工業製のFINETE
X−ES (商品名、ファインテックス−ES)が特に
良好である。Examples of the sulfonated polyester resin used in the present invention include FINETE manufactured by Dainippon Ink and Chemicals.
X-ES (trade name, Finetex-ES) is particularly good.
該樹脂は、例えば、テレフタル酸ジメチル679部、イ
ソフタル酸ジメチル225部、5−スルホイソフタル酸
ジメチル・ナトリウム塩104部、エチレングリコール
496部、ジエチレングリコール212部、酢酸亜鉛n
3部、三塩化アンチモン(15部を混合し、窒素気流下
で170〜200℃に加熱して反応させ、得られたポリ
エステル共重合体をアンモニア水で中和して得ることが
できる。該樹脂の大きな特徴は、ポリエステル中の全カ
ルボン酸成分の5〜7.5モルチがエステル形成性スル
ホン酸アルカリ金属化合物からなっていることである。The resin contains, for example, 679 parts of dimethyl terephthalate, 225 parts of dimethyl isophthalate, 104 parts of dimethyl sodium 5-sulfoisophthalate, 496 parts of ethylene glycol, 212 parts of diethylene glycol, and zinc acetate n.
The resin can be obtained by mixing 3 parts of antimony trichloride and 15 parts of antimony trichloride, reacting by heating to 170 to 200°C under a nitrogen stream, and neutralizing the resulting polyester copolymer with aqueous ammonia. A major feature of the polyester is that 5 to 7.5 moles of the total carboxylic acid component in the polyester is composed of an ester-forming alkali metal sulfonate compound.
該スルホン酸アルカリ金属化合物の含有率はこのポリエ
ステル樹脂の水溶化と、乾燥後のフィルムの強度との間
の重要な因子であり、この率が高すぎても低すぎても目
的とする性能は得られない。The content rate of the alkali metal sulfonate compound is an important factor between the water solubilization of the polyester resin and the strength of the film after drying, and if this rate is too high or too low, the desired performance will not be achieved. I can't get it.
従って、本試薬組成物は基材として親水基をもった該ポ
リエステル樹脂を使っているため、検体と接触した際の
浸み込み速度が速く、それゆえ反応時間が従来の本質的
に不溶性のフィルム形成性高分子樹脂を使った場合に比
べて、格段に短くて可能である。しかしながら別の面と
して、この試薬組成物のもともとの骨格はポリエステル
であるため、検体との接触によって完全に再溶解するこ
とはなく、反応後の面は検体が通った穴と試薬の溶けた
穴とが貫通しているものの、もとの樹脂骨格は残存した
構造になっているので支持体から剥離することはない。Therefore, since this reagent composition uses the polyester resin with hydrophilic groups as a base material, the penetration rate is fast when it comes into contact with the specimen, and therefore the reaction time is longer than that of conventional essentially insoluble films. This is much shorter than when using formable polymer resin. However, on the other hand, because the original backbone of this reagent composition is polyester, it will not completely redissolve upon contact with the analyte, and after the reaction the surface will be the hole through which the analyte passed and the hole where the reagent was dissolved. Although it penetrates through the support, the original resin skeleton remains and will not peel off from the support.
スルホン化されたポリエステル樹脂と試薬との混合液は
支持体上に塗布することによって試験片として使用に供
するが、支持体としては、該混合液と化学的に反応しな
い、一定の強度をもったものが望ましく、特に、ポリ塩
化ビュル、ポリエチレンテレフタレート、ポリカーボネ
ート、ポリプロピレン、ポリスチレン等の水不溶性の高
分子化合物のフィルム状;シート状又は棒状等の形態の
ものが良好である。A mixture of sulfonated polyester resin and reagent is used as a test piece by coating it on a support. Particularly preferred are water-insoluble polymeric compounds such as polychloride, polyethylene terephthalate, polycarbonate, polypropylene, and polystyrene in the form of a film, sheet, or rod.
かくして、体液中の特定成分を検出するための試薬とス
ルホン化されたポリエステル樹脂とを混合した混合液を
一定の厚さで支持体上に塗布し、乾燥後に得られた試薬
組成物が担持された支持体を適当な大きさに裁断して試
験片としたものは、体液、殊に血液をのせ一定時間反応
させた後に適当な方法で血球成分を除去すると、その体
液成分濃度に対応した呈色が得られることKなる。In this way, a mixture of a reagent for detecting a specific component in body fluids and a sulfonated polyester resin is applied onto a support at a constant thickness, and after drying, the resulting reagent composition is supported. When a test piece is prepared by cutting the supporting material into an appropriate size, a body fluid, especially blood, is placed on it, reacted for a certain period of time, and then blood cell components are removed using an appropriate method. This means that color can be obtained.
以下の実施例において本発明を更に詳細に説明する。な
お、本発明は下記実施例に限定されるものではない。The invention will be explained in further detail in the following examples. Note that the present invention is not limited to the following examples.
’lI例t 血液中のグルコース測定用試験片の製造
本発明のスルホン化されたポリエステル樹脂を含む試薬
組成物を用いた試験片の有効性をみるために、血液中の
グルコースを測定するための試験片を作成し、既知の樹
脂を含む試薬組成物を用いた試験片との比較を行った。Example t Production of a test strip for measuring glucose in blood In order to examine the effectiveness of a test strip using a reagent composition containing a sulfonated polyester resin of the present invention, a test strip for measuring glucose in blood was prepared. A test piece was prepared and compared with a test piece using a reagent composition containing a known resin.
(試薬組成物)
試薬成分
グルコースオキシダーゼ 48000IUペルオキ
シダーゼ 63800IUO−トリジン・二
塩酸塩 290■2.7−ジアミツフルオレン・
二塩酸塩 320■a5Mリン酸塩緩衝液(pH7
fJ ) 40mlエタノール
20au蒸留水 30m
フィルム形成成分 857■FINET
EX−ES(スルホン化ポリエステル樹脂)■ポリプロ
ピオン酸ビニル
■陰イオン性ポリウレタン分散体
上記試薬成分とフィルム形成成分■を十分混合して本発
明の試薬組成物1を調製した後、第1図に示すように縦
80rIaR%横300真の白色のポリカーボネートフ
ィルムからなる支持体2上に幅10112I!1厚さ3
00μmになるように適当な塗布方法を使って横方向に
試薬組成物1を塗布し、続いて80℃で10分間熱風乾
燥機中で乾燥した。これを縦方向5mm幅に切断し、試
験片5(試験片■)とした。同様にしてフィルム形成成
分■及び■を用いて試験片■及び0を得た。(Reagent composition) Reagent components Glucose oxidase 48,000 IU Peroxidase 63,800 IUO-tolidine dihydrochloride 290 ■ 2,7-Diamitsufluorene
Dihydrochloride 320■a5M phosphate buffer (pH 7
fJ) 40ml ethanol
20au distilled water 30m Film forming component 857■FINET
EX-ES (sulfonated polyester resin) ■Polypropionate vinyl ■Anionic polyurethane dispersion After thoroughly mixing the above reagent components and film-forming component ■ to prepare reagent composition 1 of the present invention, as shown in FIG. As shown, the width is 10112I on a support 2 made of a true white polycarbonate film with a length of 80rIaR% and a width of 300mm! 1 thickness 3
Reagent composition 1 was applied laterally using an appropriate coating method to a thickness of 0.00 μm, followed by drying in a hot air dryer at 80° C. for 10 minutes. This was cut into a width of 5 mm in the longitudinal direction to obtain a test piece 5 (test piece ■). Similarly, test pieces 1 and 0 were obtained using film-forming components 1 and 2.
試験片3上に血液を滴下し、正確に30秒後に脱脂綿で
ふき取った。結果を下記第1表に示す。Blood was dropped onto the test piece 3 and wiped off with absorbent cotton after exactly 30 seconds. The results are shown in Table 1 below.
第 1 表
次にこれらの試験片の反応性をさらに詳しく見るために
、100,200,300,500,800η/dtの
グルコースを含んだ血液を用意し、同様に操作して得ら
れた呈色を比較した。Table 1 Next, in order to examine the reactivity of these test pieces in more detail, blood containing 100, 200, 300, 500, 800 η/dt of glucose was prepared and the coloring obtained by performing the same procedure. compared.
■ !1度が濃くなるにしたがって青色が濃くなり、色
差がはっきりと認められた。■! As the temperature increased, the blue color became deeper, and a color difference was clearly observed.
■ ある程度の色差はわかるが、全体的に色が薄い。■ You can see some color difference, but the colors are pale overall.
■ 全体的に色が薄く、色差がはっきりしない。■ The color is pale overall and the color difference is not clear.
この呈色を直ちに分光光度色差計(村上色彩技術研究所
CMS−1200)を用いて、b o o nmの波長
で反射率を測定した。得られた反射率とグルコース分析
計(YSIグルコースアナライザーモデル23A)を用
いて測定したグルコース濃度とから、第2図に示すよう
な検量線が得られた。The reflectance of this color was immediately measured using a spectrophotometric colorimeter (Murakami Color Research Institute CMS-1200) at a wavelength of BO O nm. A calibration curve as shown in FIG. 2 was obtained from the obtained reflectance and the glucose concentration measured using a glucose analyzer (YSI Glucose Analyzer Model 23A).
図中、縦軸は600nmでの反射率を表わし、横軸は、
血液中のグルコース濃度を表わす。In the figure, the vertical axis represents the reflectance at 600 nm, and the horizontal axis represents
Represents the glucose concentration in the blood.
以上のようKいずれの試験片も血球の除去は良好である
が、反応性においては本発明の試験片■が、他の試験片
に比べて良好なことが判明した。すなわち試験片■や0
では、フィルム形成成分が本質的に水不溶性なため、フ
ィルム開放剤としての微細粒子や水膨潤性成分がないと
検体の浸透性を良くできず、従ってこれらの成分が不可
欠となるのである。ところが本発明の試験片のには、樹
脂自身に水溶性が付与されているため、検体の浸み込み
が良く、特別な浸透性改善のだめの手段が必要ないので
ある。As mentioned above, all of the K test pieces were good at removing blood cells, but in terms of reactivity, the test piece (2) of the present invention was found to be better than the other test pieces. In other words, test piece ■ or 0
Since the film-forming components are essentially water-insoluble, the permeability of the specimen cannot be improved without fine particles and water-swellable components as film release agents, and these components are therefore essential. However, in the test piece of the present invention, since the resin itself has water solubility, the specimen penetrates easily, and there is no need for special measures to improve permeability.
実施例2 血液中の乳酸測定用試験片の製造血液中の乳
酸を測定するための試験片を作成するために1次の組成
の試薬組成物を調製した。Example 2 Production of a test piece for measuring lactic acid in blood In order to create a test piece for measuring lactic acid in blood, a reagent composition having the following composition was prepared.
乳酸オキシダーゼ 21000IUペルオキ
シダーゼ 37000IU4−アミノアンチ
ビリン 244■1Mトリス塩酸緩衝液(pH7
,5) 25v?蒸留水 3〇
−
FINETEX−ES 50を上記の成分
を十分混合した後、塗布厚fzr:450μmとした他
は実施例1と同様の方法で、白色のポリ塩化ビニルフィ
ルム上に塗布し、続いて70℃で15分間熱風乾燥機中
で乾燥して試験片を得た。この試験片上に血液を滴下後
ふきとると、乳酸濃度に応じた紫色の呈色が得られる。Lactate oxidase 21,000 IU Peroxidase 37,000 IU 4-aminoantivirine 244 ■ 1M Tris-HCl buffer (pH 7)
,5) 25v? Distilled water 30 - After thoroughly mixing the above components, FINE TEX-ES 50 was applied onto a white polyvinyl chloride film in the same manner as in Example 1, except that the coating thickness fzr was 450 μm, and then A test piece was obtained by drying in a hot air dryer at 70°C for 15 minutes. When blood is dropped onto this test piece and wiped off, a purple coloration corresponding to the lactic acid concentration is obtained.
上述の如く、本発明の体液中成分検出用試薬組成物は、
体液中の特定成分を検出するための試薬の担体としてス
ルホン化されたポリエステル樹脂を用いるため、製造が
容易であるとともに担体が親水性であるので検体の浸み
込み速度が速く、判定結果が正確かつ迅速に得られる。As mentioned above, the reagent composition for detecting components in body fluids of the present invention includes:
Since sulfonated polyester resin is used as a carrier for reagents used to detect specific components in body fluids, it is easy to manufacture, and since the carrier is hydrophilic, the sample penetrates quickly and the determination results are accurate. and can be obtained quickly.
又、本発明の試験片は上記試薬組成物を支持体上に塗布
するのみで容易に得ることができ、安価であるとともに
構造も簡単なので種々の変形も容易であり、使い易−く
信頼性が高い。In addition, the test piece of the present invention can be easily obtained by simply applying the above-mentioned reagent composition onto a support, is inexpensive, has a simple structure, and can be easily modified in various ways, and is easy to use and reliable. is high.
第1図は本発明の体液中成分検出用試験片の一実施例の
製造工程の説明図、
第2図は、実施例1の試験片(■〜C)を用いて得た検
量線を示す図である。
図中、
1・・・試薬組成物 2・・・支持体3・・・試験
片
特許出願人 栄研化学株式会社
(ほか2名)
ミ甚:1.+!!Figure 1 is an explanatory diagram of the manufacturing process of one embodiment of the test piece for detecting components in body fluids of the present invention. Figure 2 shows the calibration curve obtained using the test pieces (■ to C) of Example 1. It is a diagram. In the figure, 1... Reagent composition 2... Support 3... Test piece patent applicant Eiken Chemical Co., Ltd. (and 2 others) Mijin: 1. +! !
Claims (3)
薬の担体としてのスルホン化されたポリエステル樹脂と
よりなることを特徴とする体液中成分検出用試薬組成物
。(1) A reagent composition for detecting a component in a body fluid, comprising a reagent for detecting a specific component in a body fluid, and a sulfonated polyester resin as a carrier for the reagent.
基が、エステル形成性スルホン酸アルカリ金属化合物と
して全カルボン酸成分に対して5〜7.5モル%含有さ
れることを特徴とする請求項1記載の試薬組成物。(2) The sulfone group in the sulfonated polyester resin is contained in an amount of 5 to 7.5 mol% based on the total carboxylic acid component as an ester-forming alkali metal sulfonate compound. reagent composition.
布されたことを特徴とする体液中成分検出用試験片。(3) A test piece for detecting components in body fluids, comprising a support coated with the reagent composition according to claim 1 or 2.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2851588A JPH01202659A (en) | 1988-02-09 | 1988-02-09 | Reagent composition and test piece for detecting component in body fluid |
DE19893903126 DE3903126A1 (en) | 1988-02-09 | 1989-02-02 | Reagent composition and test strips for detecting constituents in body fluids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2851588A JPH01202659A (en) | 1988-02-09 | 1988-02-09 | Reagent composition and test piece for detecting component in body fluid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01202659A true JPH01202659A (en) | 1989-08-15 |
Family
ID=12250822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2851588A Pending JPH01202659A (en) | 1988-02-09 | 1988-02-09 | Reagent composition and test piece for detecting component in body fluid |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPH01202659A (en) |
DE (1) | DE3903126A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7476533B2 (en) | 2002-04-19 | 2009-01-13 | Adhesives Research, Inc. | Diagnostic devices for use in the assaying of biological fluids |
AU2002258867B2 (en) * | 2001-04-19 | 2007-07-26 | Adhesives Research, Inc. | Hydrophilic diagnostic devices |
-
1988
- 1988-02-09 JP JP2851588A patent/JPH01202659A/en active Pending
-
1989
- 1989-02-02 DE DE19893903126 patent/DE3903126A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE3903126A1 (en) | 1989-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4824640A (en) | Transparent test strip system | |
US4824639A (en) | Test device and a method for the detection of a component of a liquid sample | |
EP0016387B1 (en) | Diagnostic means for the determination of components of liquids | |
AU601639B2 (en) | Process for the production of porous membranes, the membranes produced thereby and their use as supporting matrices in test strips | |
JP3342077B2 (en) | Improved oxidative coupling dyes for spectrophotometric determination of analytes | |
DE2819645A1 (en) | MEANS AND METHODS OF IMPLEMENTING COLORIMETRIC OR PHOTOMETRIC DETERMINATIONS | |
JP2004503760A (en) | Compositions containing urea derivative dyes for detecting analytes | |
JPS59120958A (en) | Test piece and its manufacture | |
US5096833A (en) | Method and device for determining protein using carrier matrix composed of urethane, water insouble inorganic compound and insoluble organic compound and method of making the device | |
JPS59228166A (en) | Tester and method of measuring presence of substance in sample and manufacture of tester | |
JPS59143959A (en) | Dry analytical element | |
JPH02201163A (en) | Testing method and apparatus for measuring total protein | |
JPH01202659A (en) | Reagent composition and test piece for detecting component in body fluid | |
JPH0625760B2 (en) | Method of manufacturing test pieces by casting method | |
DE69731929T2 (en) | Dry reagent assay element | |
JP4889670B2 (en) | Dry analytical element for measuring body fluid components with reduced hemolysis | |
CA1338525C (en) | Dry powder diagnostic reagent and applications thereof | |
CN100569348C (en) | The method of coated film | |
JPS6014141A (en) | Monolithically multilayered analyzing implement | |
JPH03205562A (en) | Body fluid inspecting matter | |
JP3855008B2 (en) | Filter paper used under acid-containing condition or acidic condition and test piece formed using the filter paper | |
JPS585200A (en) | Diagnostic material for detecting and measuring cholesterine and cholesterine ester in blood | |
JPH02247546A (en) | Production of analyzing element | |
JPH02226052A (en) | Manufacture of analysis element | |
JPH02189440A (en) | Manufacture of test piece |